Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment (COMFORT)-I study

被引：3
作者：
Kosiorek, Heidi E. [1 ]
Scherber, Robyn M. [2 ]
Geyer, Holly L. [3 ]
Verstovsek, Srdan [4 ]
Langlais, Blake T. [1 ]
Mazza, Gina L. [1 ]
Gotlib, Jason [5 ]
Gupta, Vikas [6 ]
Padrnos, Leslie J. [7 ]
Palmer, Jeanne M. [7 ]
Fleischman, Angela [8 ]
Mesa, Ruben A. [9 ]
Dueck, Amylou C. [1 ]
机构：
[1] Mayo Clin, Dept Quantitat Hlth Sci, Johnson Res Bldg,13400 E Shea Blvd, Scottsdale, AZ 85259 USA
[2] Blueprint Med, Cambridge, MA USA
[3] Mayo Clin, Dept Internal Med, Scottsdale, AZ USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[5] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[6] Univ Toronto, Princess Margaret Canc Ctr, MPN Program, Toronto, ON, Canada
[7] Mayo Clin, Dept Hematol & Oncol, Phoenix, AZ USA
[8] Univ Calif Irvine, Dept Hematol & Oncol, Irvine, CA USA
[9] UT Hlth San Antonio MD Anderson, Mays Canc Ctr, San Antonio, TX USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2022年 / 198卷 / 06期
关键词：
myelofibrosis; prognostic factors; quality of life; survival; PATIENT-REPORTED OUTCOMES; SYMPTOM BURDEN; RUXOLITINIB;
D O I：
10.1111/bjh.18329
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1065 / 1068
页数：4
相关论文
共 15 条
  • [1] Association of frailty with clinical outcomes in myelofibrosis: a retrospective cohort study
    Bankar, Aniket
    Alibhai, Shabbir
    Smith, Elliot
    Yang, Dongyang
    Malik, Sarah
    Cheung, Verna
    Siddiq, Nancy
    Claudio, Jaime
    Arruda, Andrea
    Tsui, Hubert
    Capo-Chichi, Jose-Mario
    Kennedy, James A.
    McNamara, Caroline
    Sibai, Hassan
    Maze, Dawn
    Xu, Wei
    Gupta, Vikas
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (03) : 557 - 567
  • [2] Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis
    Cervantes, Francisco
    Vannucchi, Alessandro M.
    Kiladjian, Jean-Jacques
    Al-Ali, Haifa Kathrin
    Sirulnik, Andres
    Stalbovskaya, Viktoriya
    McQuitty, Mari
    Hunter, Deborah S.
    Levy, Richard S.
    Passamonti, Francesco
    Barbui, Tiziano
    Barosi, Giovanni
    Harrison, Claire N.
    Knoops, Laurent
    Gisslinger, Heinz
    [J]. BLOOD, 2013, 122 (25) : 4047 - 4053
  • [3] Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis
    Efficaee, Fabio
    Collins, Gary S.
    Cottone, Francesco
    Giesinger, Johannes M.
    Sommer, Kathrin
    Anota, Amelie
    Schlussel, Michael Maia
    Fazi, Paola
    Vignetti, Marco
    [J]. VALUE IN HEALTH, 2021, 24 (02) : 250 - 267
  • [4] Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
    Emanuel, Robyn M.
    Dueck, Amylou C.
    Geyer, Holly L.
    Kiladjian, Jean-Jacques
    Slot, Stefanie
    Zweegman, Sonja
    te Boekhorst, Peter A. W.
    Commandeur, Suzan
    Schouten, Harry C.
    Sackmann, Federico
    Kerguelen Fuentes, Ana
    Hernandez-Maraver, Dolores
    Pahl, Heike L.
    Griesshammer, Martin
    Stegelmann, Frank
    Doehner, Konstanze
    Lehmann, Thomas
    Bonatz, Karin
    Reiter, Andreas
    Boyer, Francoise
    Etienne, Gabriel
    Ianotto, Jean-Christophe
    Ranta, Dana
    Roy, Lydia
    Cahn, Jean-Yves
    Harrison, Claire N.
    Radia, Deepti
    Muxi, Pablo
    Maldonado, Norman
    Besses, Carlos
    Cervantes, Francisco
    Johansson, Peter L.
    Barbui, Tiziano
    Barosi, Giovanni
    Vannucchi, Alessandro M.
    Passamonti, Francesco
    Andreasson, Bjorn
    Ferarri, Maria L.
    Rambaldi, Alessandro
    Samuelsson, Jan
    Birgegard, Gunnar
    Tefferi, Ayalew
    Mesa, Ruben A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (33) : 4098 - 4103
  • [5] Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?
    Langlais, Blake T.
    Geyer, Holly
    Scherber, Robyn
    Mesa, Ruben A.
    Dueck, Amylou C.
    [J]. LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 402 - 408
  • [6] Maffioli M., 2022, BLOOD ADV, V6, P1855, DOI DOI 10.1182/BLOODADVANCES.2021006889
  • [7] Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis
    Mannelli, Francesco
    Bencini, Sara
    Coltro, Giacomo
    Loscocco, Giuseppe G.
    Peruzzi, Benedetta
    Rotunno, Giada
    Maccari, Chiara
    Gesullo, Francesca
    Borella, Miriam
    Paoli, Chiara
    Caporale, Roberto
    Mannarelli, Carmela
    Annunziato, Francesco
    Guglielmelli, Paola
    Vannucchi, Alessandro M.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (07) : 846 - 855
  • [8] Reducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitors
    Mesa, Ruben A.
    Scherber, Robyn M.
    Geyer, Holly L.
    [J]. LEUKEMIA & LYMPHOMA, 2015, 56 (07) : 1989 - 1999
  • [9] Mierzynska J, 2019, LANCET ONCOL, V20, pE685, DOI 10.1016/S1470-2045(19)30656-4
  • [10] Singh JA., 2021, J CLIN EPIDEMIOL
12